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In this issue of Blood, Welsh and colleagues determine how platelet thrombi 
limit the loss of plasma-borne proteins from the microvasculature. 1 
 
The concept that platelets prevent leakage from blood vessels following a 
penetrating injury will come as little surprise to most readers, but exactly how 
platelets physically contribute to this process is not well understood.  Such 
injuries result in the loss of blood cells and plasma into the surrounding 
tissues, and both forms of loss must be halted quickly.  Platelets are believed 
to form the first line of defense in such situations, forming a thrombus that is 
capable of plugging the hole and supplying molecules that contribute to 
localized inflammation and wound healing. 
 
In recent years innovations in intravital microscopy have provided insight into 
the control mechanisms that allow platelet thrombi to form within the 
microcirculation of mice.  Such approaches allow the accumulation of platelets 
at sites of vascular injury to be visualized and quantified, enabling the roles of 
specific proteins to be assessed, exploiting transgenic mice, selective 
inhibitors or pharmacological agents 2. A range of injury models have been 
developed for intravital analysis including mechanical, chemical, 
photochemical and electrical injury, and a model that has gained extensive 
use is focal injury using a laser 3.    
 
In a recent series of studies the architecture of thrombi formed in mice has 
been explored 4, 5.  Thrombi formed in cremaster muscle arterioles possess a 
zoned structure, with a tightly packed inner core of platelets which results 
from outside-in signalling through integrin IIb3, pulling platelets closer 
together 6, 7.  Secondary platelet agonists emanating from activated platelets 
on the edge of the core cause the accumulation of platelets that form a less 
densely packed shell layer.  A consequence of the tightly packed core is 
restricted permeation of plasma-borne molecules through the core, and 
therefore greater local thrombin activity resulting in fibrin formation and 
increased platelet activation 6-9.  Indeed, inhibition of thrombin disrupts 
thrombus core structure, while the size of the thrombus shell is reduced in the 
presence of ADP receptor antagonists 6.    
 
In this issue Welsh et al have explored which features of the heterogeneous 
architecture of platelet thrombi explain their ability to seal blood vessels to 
achieve ‘plasma stasis’, and determined whether the use of antiplatelet and 
anticoagulant agents which impair thrombus structure interfere with the 
formation of a vascular seal 1.  To achieve this goal an elegant method was 
developed in which albumin conjugated to caged fluorophore was infused into 
mice.  Repeated uncaging of the sensor with light in the vicinity of thrombi 
formed following penetrating laser injury allowed extravascular accumulation 
and dispersion of plasma proteins to be measured in real-time. 
 
Thrombus formation was studied in cremaster muscle venules, in which the 
heterogeneous thrombus structure previously observed in arterioles was also 
observed.  While cessation of red blood cell leakage occurred within seconds 
of injury, plasma protein leakage continued over a period of minutes, although 
dramatic reductions in this occurred during the first 3 minutes, beyond the 
point of maximum platelet and fibrin accumulation, suggesting that structural 
changes within the thrombus may control the leakage of plasma.  Indeed, 
infusion of eptifibatide to block integrin IIb3, which reduced platelet 
accumulation but had no effect on peak fibrin production or red cell loss, 
resulted in increased albumin leakage.  Interestingly, increasing the 
recruitment of platelets to thrombi in transgenic mice expressing Gi2 did not 
enhance vessel sealing, suggesting that thrombus size alone did not explain 
the hemostatic potential of a thrombus.   
 
These observations led the team to establish whether defective platelet 
retraction altered vessel leakiness.  This was studied in transgenic mice in 
which integrin IIb3 is incapable of outside-in signaling 10.   Plasma leakage 
was extended following initial reductions as thrombi formed.  This suggests 
that platelet recruitment controls initial reductions in plasma leakage, with 
platelet retraction and resultant intrathrombus remodeling further reducing 
loss of plasma. 
 
So how do these observations relate to the zoned structures of thrombi?  One 
clue comes from the ability of eptifibatide to greatly increase leakage of 
labeled albumin, while peak fibrin levels were unaltered, which may suggest, 
surprisingly, that plasma stasis in not dependent on fibrin.  This was tested 
through infusion of the thrombin antagonist hirudin, which abolished fibrin 
accumulation and reduced thrombus size, but vessel sealing was unaffected.  
Conversely, infusion of an ADP receptor antagonist that resulted in a 
reduction in the size of the P-selectin-negative shell, was associated with 
increased plasma protein extravasation.  This indicates a key role for ADP, 
while suggesting that -granule secretion (noted by P-selectin exposure) is 
not directly linked to tight vascular sealing.   
 
Further scrutiny of labeled albumin extravasation and dispersion rates 
revealed that in conditions (or transgenic mice) where plasma leakage was 
enhanced, accumulation rates exceeded dispersion rates.  Therefore changes 
in thrombus architecture, for example following exposure to ADP receptor 
antagonists, that upset the likelihood of extravasation rates falling below 
dispersion, result in increased escape of proteins into surrounding tissues.   
 
Previous studies have indicated that the zoned structure of a platelet 
thrombus is required to enable localized accumulation of different agonists 
within the thrombus, which in turn reinforce this structure through contraction 
of the core and the formation of a gradient of ADP and thromboxane A2 
allowing shell growth.  This current study indicates the potential importance of 
distinctive intrathrombus zones, because the prevention of the loss of plasma 
proteins requires platelet accumulation, ADP-dependent platelet signalling 
and platelet contraction.  It will be important to determine whether the 
phenomena discovered in this study are observed following other forms of 
vascular injury, noting that some variability in leakage measurements in the 
present study may have been due to different extents of injury.  Further work 
will also be needed to determine whether similar properties of platelet thrombi 
are observed in arterioles and in the macrocirculation.   
 
This study provides new insight into the molecular and physiological 
processes that ensure that blood vessel leakage is prevented following 
penetrating injury and indicates how antiplatelet agents may delay the 
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A.  The accumulation of platelets at site of penetrating vascular injury forms a 
vascular seal to prevent loss of plasma proteins.  B. The prevention of 
vascular leakage is enhanced by intrathrombus remodeling through ADP and 
integrin IIb3 signaling resulting in formation of a contracted thrombus core.  
Adapted from Welsh et al. 1 figure 7 with permission. 
 
 
